Literature DB >> 29924130

In-person and telemedicine course models for disaster preparedness: a comparative analysis.

Alcir Escocia Dorigatti1, Bruno Monteiro Tavares Pereira1, Romeo Lages Simões1, Juliana Rodrigues Matsuguma1, Thiago Rodrigues Araujo Calderan1, Gustavo Pereira Fraga1.   

Abstract

OBJECTIVE: to compare the students' performance in face-to-face and telemedicine courses for the training and necessary action in disasters, using telemedicine as an effective training tool.
METHODS: online research conducted after the end of the course of preparation in disasters, carried out in-person, as well as by videoconference. We compared the performance of students in the in-person course and through telemedicine.
RESULTS: in the comparison of the results obtained with the pre- and post-test data between the students who attended via telemedicine and in-person, we observed that in the two modalities there was an increase in knowledge (p<0.001). We also observed no statistically significant differences in the posterior evaluation between the in-person and telemedicine courses (p=1.0), however, there was a significant difference at the pre-test evaluative moment (p<0.001).
CONCLUSION: videoconferencing can be effectively used to train health professionals in disaster management, being able to provide adequate knowledge and become an important tool to distance reaching in continuing education.

Entities:  

Mesh:

Year:  2018        PMID: 29924130     DOI: 10.1590/0100-6991e-20181710

Source DB:  PubMed          Journal:  Rev Col Bras Cir        ISSN: 0100-6991


  2 in total

Review 1.  Telemedicine: a Bridge Over Knowledge Gaps in Healthcare.

Authors:  Evelyn Eisenstein; Cristiane Kopacek; Suzy Santana Cavalcante; Almir C Neves; Gustavo P Fraga; Luiz Ary Messina
Journal:  Curr Pediatr Rep       Date:  2020-07-01

2.  Survey of awareness of radiation disasters among firefighters in a Japanese prefecture without nuclear power plants.

Authors:  Koji Yamada; Izumi Yamaguchi; Hideko Urata; Naomi Hayashida
Journal:  PLoS One       Date:  2020-07-27       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.